A common methylenetetrahydrofolate reductase gene mutation and longevity

Citation
L. Brattstrom et al., A common methylenetetrahydrofolate reductase gene mutation and longevity, ATHEROSCLER, 141(2), 1998, pp. 315-319
Citations number
19
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
ATHEROSCLEROSIS
ISSN journal
00219150 → ACNP
Volume
141
Issue
2
Year of publication
1998
Pages
315 - 319
Database
ISI
SICI code
0021-9150(199812)141:2<315:ACMRGM>2.0.ZU;2-T
Abstract
Homozygotes (TT genotype) for the C677T mutation in the gene of methylenete trahydrofolate reductase (C677T/MTHFR mutation) constitute about 12% of the Caucasian population, They have mild hyperhomocysteinemia which is an esta blished risk factor for cardiovascular disease. If the mutation is associat ed with premature death its prevalence is expected to be lower in the elder ly than in the young. To test this we determined the C677T/MTHFR genotypes in 220 newborn and 222 elderly 80-108-year-old Swedes. In the newborn and e lderly, the allele frequency, of the C677T/MTHFR mutation was 29.1 and 27.0 % and the mutant homozygote frequency was 10.0 and 9.5%, respectively. In a meta analysis of the present and three previous studies including a total of 1388 elderly and 1415 younger subjects, the odds ratio (OR) representing the likelihood of the TT genotype to attain old age relative to the CC gen otype was 0.87 (95% confidence interval (CI), 0.69-1.11) and relative to bo th the CC and CT genotypes was 0.83 (95% CI, 0.66-1.04). This finding does not suggest that the C677T/MTHFR mutation is a strong risk factor for disea ses frequently leading to premature death. (C) 1998 Elsevier Science Irelan d Ltd. All rights reserved.